161 related articles for article (PubMed ID: 16051859)
1. Generation of an influenza A virus vector expressing biologically active human interleukin-2 from the NS gene segment.
Kittel C; Ferko B; Kurz M; Voglauer R; Sereinig S; Romanova J; Stiegler G; Katinger H; Egorov A
J Virol; 2005 Aug; 79(16):10672-7. PubMed ID: 16051859
[TBL] [Abstract][Full Text] [Related]
2. Hyperattenuated recombinant influenza A virus nonstructural-protein-encoding vectors induce human immunodeficiency virus type 1 Nef-specific systemic and mucosal immune responses in mice.
Ferko B; Stasakova J; Sereinig S; Romanova J; Katinger D; Niebler B; Katinger H; Egorov A
J Virol; 2001 Oct; 75(19):8899-908. PubMed ID: 11533153
[TBL] [Abstract][Full Text] [Related]
3. Rescue of influenza virus expressing GFP from the NS1 reading frame.
Kittel C; Sereinig S; Ferko B; Stasakova J; Romanova J; Wolkerstorfer A; Katinger H; Egorov A
Virology; 2004 Jun; 324(1):67-73. PubMed ID: 15183054
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and protection efficacy of replication-deficient influenza A viruses with altered NS1 genes.
Ferko B; Stasakova J; Romanova J; Kittel C; Sereinig S; Katinger H; Egorov A
J Virol; 2004 Dec; 78(23):13037-45. PubMed ID: 15542655
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of human T cells by an influenza A vector expressing a CTL epitope from the HER-2/neu protooncogene results in higher numbers of antigen-specific TCRhi cells than stimulation with peptide. Divergent roles of IL-2 and IL-15.
Efferson CL; Kawano K; Tsuda N; Palese P; García-Sastre A; Ioannides CG
Anticancer Res; 2005; 25(2A):715-24. PubMed ID: 15868901
[TBL] [Abstract][Full Text] [Related]
6. Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes.
Basler CF; Reid AH; Dybing JK; Janczewski TA; Fanning TG; Zheng H; Salvatore M; Perdue ML; Swayne DE; García-Sastre A; Palese P; Taubenberger JK
Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2746-51. PubMed ID: 11226311
[TBL] [Abstract][Full Text] [Related]
7. [Rescued influenza A virus with codon deoptimized NS1 gene is attenuated both in vitro and in vivo].
Luan S; Pan W; Li T; Yang H; Zhang B; Li F; Chen L
Sheng Wu Gong Cheng Xue Bao; 2009 May; 25(5):720-6. PubMed ID: 19670641
[TBL] [Abstract][Full Text] [Related]
8. The ORF, regulated synthesis, and persistence-specific variation of influenza C viral NS1 protein.
Marschall M; Helten A; Hechtfischer A; Zach A; Banaschewski C; Hell W; Meier-Ewert H
Virology; 1999 Jan; 253(2):208-18. PubMed ID: 9918879
[TBL] [Abstract][Full Text] [Related]
9. A site on the influenza A virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis.
Min JY; Li S; Sen GC; Krug RM
Virology; 2007 Jun; 363(1):236-43. PubMed ID: 17320139
[TBL] [Abstract][Full Text] [Related]
10. Recombinant influenza A viruses harboring optimized dicistronic NA segment with an extended native 5' terminal sequence: induction of heterospecific B and T cell responses in mice.
Vieira Machado A; Naffakh N; Gerbaud S; van der Werf S; Escriou N
Virology; 2006 Feb; 345(1):73-87. PubMed ID: 16271378
[TBL] [Abstract][Full Text] [Related]
11. Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach.
Talon J; Salvatore M; O'Neill RE; Nakaya Y; Zheng H; Muster T; García-Sastre A; Palese P
Proc Natl Acad Sci U S A; 2000 Apr; 97(8):4309-14. PubMed ID: 10725408
[TBL] [Abstract][Full Text] [Related]
12. [Study progress of NS1 protein of influenza A virus].
Li JL; Zhang WP; Bi DR
Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):729-33. PubMed ID: 17944383
[TBL] [Abstract][Full Text] [Related]
13. A GFP expressing influenza A virus to report in vivo tropism and protection by a matrix protein 2 ectodomain-specific monoclonal antibody.
De Baets S; Verhelst J; Van den Hoecke S; Smet A; Schotsaert M; Job ER; Roose K; Schepens B; Fiers W; Saelens X
PLoS One; 2015; 10(3):e0121491. PubMed ID: 25816132
[TBL] [Abstract][Full Text] [Related]
14. Development of a live-attenuated influenza B DeltaNS1 intranasal vaccine candidate.
Wressnigg N; Voss D; Wolff T; Romanova J; Ruthsatz T; Mayerhofer I; Reiter M; Nakowitsch S; Humer J; Morokutti A; Muster T; Egorov A; Kittel C
Vaccine; 2009 May; 27(21):2851-7. PubMed ID: 19366569
[TBL] [Abstract][Full Text] [Related]
15. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
[TBL] [Abstract][Full Text] [Related]
16. Introduction of foreign sequences into the genome of influenza A virus.
García-Sastre A; Percy N; Barclay W; Palese P
Dev Biol Stand; 1994; 82():237-46. PubMed ID: 7525392
[TBL] [Abstract][Full Text] [Related]
17. A genetically engineered influenza A virus with ras-dependent oncolytic properties.
Bergmann M; Romirer I; Sachet M; Fleischhacker R; García-Sastre A; Palese P; Wolff K; Pehamberger H; Jakesz R; Muster T
Cancer Res; 2001 Nov; 61(22):8188-93. PubMed ID: 11719449
[TBL] [Abstract][Full Text] [Related]
18. Variation in the ability of human influenza A viruses to induce and inhibit the IFN-beta pathway.
Hayman A; Comely S; Lackenby A; Murphy S; McCauley J; Goodbourn S; Barclay W
Virology; 2006 Mar; 347(1):52-64. PubMed ID: 16378631
[TBL] [Abstract][Full Text] [Related]
19. [Effect of influenza virus NS1 protein on host cell].
Zhao L; Zhang Y; Yang Z; Xu L; Yang Y; Yu M; Wang R; Zhou X; Huang P
Sheng Wu Gong Cheng Xue Bao; 2008 Nov; 24(11):1912-7. PubMed ID: 19256338
[TBL] [Abstract][Full Text] [Related]
20. Enhanced humoral HIV-1-specific immune responses generated from recombinant rhabdoviral-based vaccine vectors co-expressing HIV-1 proteins and IL-2.
McGettigan JP; Koser ML; McKenna PM; Smith ME; Marvin JM; Eisenlohr LC; Dietzschold B; Schnell MJ
Virology; 2006 Jan; 344(2):363-77. PubMed ID: 16226782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
